Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 gemcitabine/carboplatin with or without BSI-201 (SAR240550) in stage IV squamous NSCLC
2010-019255-22Phase 3Completed
- Sponsor
- BiPar Sciences
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Pulmonary squamous cell carcinoma comparing Gemcitabine + carboplatin + BSI-201 with Gemcitabine + carboplatin + placebo (2 arms). Primary endpoint: Overall survival. Started Jun 2010; status: completed.
02
Drugs
iniparib
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on 2010-019255-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019255-22.